IQ4I
COVID-19 Pandemic
The world is now under the grip of "COVID-19 pandemic", the normal life of citizens of the world has been impacted and not mention businesses of all sizes either its small or large. As people are striving to save themselves from this global scare, we at IQ4I are offering innovative solutions to these challenges. Here is the list of market research reports published by IQ4I that would arm you with market intelligence data and support you to face the challenge with confidence.
Monitoring & diagnostics: Respiratory Care Devices, Fetal and Neonatal Care Devices, Cerebral and Pulse Oximeter, Patient Monitoring
Invitro diagnostics: In Vitro Diagnostics, Molicular Diagnostics, Liquid Biopsys etc
Protection: Sterilization and Disinfection
Technologies: Polymerase Chain Reaction, Next-Generation Sequencing, Proteomics
Coronavirus disease (COVID-19) is an infectious disease caused by a new virus. CoVs are positive-stranded RNA viruses with a crown-like appearance under an electron microscope (coronam is the Latin term for crown) due to the presence of spike glycoproteins on the envelope. The disease causes respiratory illness (like the flu) with symptoms such as a cough, fever, sore through and in more severe cases, difficulty breathing. These symptoms may appear 2-14 days after exposure. In extreme cases Pneumonia, Kidney failure and death. COVID-19 has a mortality rate of 3.8 to 5.8%.
- Virus enters through the nose and mouth
- Finds a host cell in the respiratory system
- Host cell then bursts and infects other cells nearby
Basic protective measures:
Most people who become infected experience mild illness and recover, but it can be more severe for others. Take care of your health and protect others by doing the following:
Wash your hands frequently
- Regularly and thoroughly clean your hands with an alcohol-based hand rub or wash them with soap and water.
Maintain social distancing
- Maintain at least 1 meter (3 feet) distance between yourself and anyone who is coughing or sneezing.
Avoid touching eyes, nose and mouth
Practice respiratory hygiene
- Covering your mouth and nose with your bent elbow or tissue when you cough or sneeze and dispose of the used tissue immediately.
Novel Corona virus first spread to human from an animal- thought to be a snake – at the South China Seafood Wholesale market.
When to Seek Medical Attention:
If you develop emergency warning signs for COVID-19 get medical attention immediately. Emergency warning signs include
- Trouble breathing
- Persistent pain or pressure in the chest
- Inability to arouse
- Bluish lips or face
Companies working on COVID-19
A total of 16 companies are working to tackle COVID 19 pandemic. Of which 6 are focused on treatment, 8 are focused on vaccine and 2 companies have focused on treatment + vaccine.
Organization | Type | Target | Phase | Current Status and Plan | Timeline |
---|---|---|---|---|---|
Abbvie | Treatment | lopinavir/ritonavir combination | 3 | The company is collaborating with select health authorities and institutions globally to determine antiviral activity as well as efficacy and safety of lopinavir/ritonavir against COVID-19. | NA |
Gilead | Treatment | Remdesivir | 3 | Remdesivir is now being tested in five Covid-19 clinical trials that have been set up at breakneck speed. | CT results are expected in April 2020 |
Vaccitech | Vaccine | lopinavir/ritonavir combination | 2b | A platform to new next-generation sequencing workflows focused in microbiology and infectious disease, including for the novel coronavirus. | Started in March 2020 |
Ascletis | Treatment | Combination of two antivirals | 1 | The Chinese manufacturer is testing a combination of antivirals, one approved for HIV and one approved for hepatitis C, that might treat coronavirus infection | NA |
CanSinoBio | Vaccine | Covid-19 vaccine | 1 | CanSino's approach involves taking a snippet of coronavirus' genetic code and entwining it with a harmless virus, thereby exposing healthy volunteers to the novel infection and spurring the production of antibodies. | CT to be started in March 2020 |
Moderna | Vaccine | mRNA-1273 | 1 | A vaccine candidate was identified by Moderna just 42 days after the novel coronavirus was sequenced. The clinical trial started recruiting healthy participants in the first week of March. | CT results are expected in summer 2020 |
AbCellera - Eli Lilly | Treatment | Antibody drug | Preclinical | Eli Lilly has partnered with a Canadian firm called AbCellera to develop antibody treatments for coronavirus infection. Using a blood sample from a coronavirus survivor, AbCellera identified more than 500 antibodies that might protect against the virus. | CTs in humans to be started in the next four months of 2020 |
Arcturus | Vaccine | Covid-19 vaccine | Preclinical | The company in partnership with Duke University plans to take an RNA virus that has been edited to encode for proteins that will protect against infection and load it into a liquid nanoparticle. | CT to be started in March-April 2020 |
GSK | Vaccine | Covid-19 vaccine | Preclinical | GSK is lending its technology to a Chinese – Clover Biopharmaceuticals – at work on a coronavirus vaccine. Clover’s approach involves injecting proteins that spur an immune response, thereby priming the body to resist infection. | NA |
Hoth Therapeutics | Vaccine | Self-assembling vaccine (SAV) | Preclinical | An agreement with Voltron Therapeutics was signed, to form a “HaloVax” JV, to commence preclinical studies for the development of vaccine prospects against COVID-19 based upon VaxCelerate, a self-assembling vaccine (SAV) platform. | End of March 2020 |
Innovio | Vaccine | Covid-19 vaccine | Preclinical | Inovio has spent the last four decades working to turn DNA into medicine, and the company believes its technology could quickly generate a vaccine for the novel coronavirus. The company has partnered with a Chinese manufacturer, Beijing Advaccine Biotechnology. | CTs are planned to be started in April 2020 |
JnJ | Vaccine | Covid-19 vaccine | Preclinical | J&J is using the same vaccine platform it used to develop its Ebola vaccine | R&D – in Jan 2020 & CT to be started by the end of Nov 2020 |
Pfizer BioNtech | Treatment + Vaccine | New mRNA vaccine | Preclinical | Co-development of a new product clinical testing in humans. Germany’s BioNTech uses strands of mRNA to spur the production of protective antibodies. | CTs are planned to be started in April 2020 |
Regeneron | Treatment | Monoclonal antibody therapy | Preclinical | To select the top 2 antibodies for a cocktail therapy, which can either be administered to at-risk people before exposure as a vaccine or as treatment for those already infected. | Potential to enter human CT by early summer 2020 |
Takeda | Treatment | Polyclonal antibody therapy | Preclinical | Collaboration with several health and regulatory agencies and health care partners across the globe on its TAK-888. The company is trying to access to source plasma from people who have successfully recovered from COVID-19 | Started in March 2020 |
COVID-19 infected cases
Total Cases | New Cases (+) | Total Deaths | New Deaths (+) | Total Recovered | Active Cases | Critical cases | |
---|---|---|---|---|---|---|---|
World | 1,432,457 | 1,538 | 82,114 | 80 | 302,308 | 1,048,035 | 47,915 |
Total No. of COVID 19 tests conducted: 10,270,112 (Approximated) |
Number of COVID 19 infected cases in each country, territory or province
United States | 4,01,608 | Bulgaria | 577 | Bermuda | 39 |
Spain | 1,41,942 | Puerto Rico | 573 | Zambia | 39 |
Italy | 1,35,586 | Latvia | 548 | Bahamas | 33 |
Germany | 1,07,659 | Lebanon | 548 | Guinea-Bissau | 33 |
China (mainland) | 81,802 | Andorra | 545 | Guyana | 33 |
France | 78,167 | Slovakia | 534 | Saint Martin | 32 |
Iran | 62,589 | Uzbekistan | 520 | Eritrea | 31 |
United Kingdom | 55,242 | Cyprus | 484 | Gabon | 30 |
Turkey | 34,109 | Costa Rica | 483 | Benin | 26 |
Switzerland | 22,253 | Afghanistan | 423 | Haiti | 25 |
Belgium | 22,194 | Uruguay | 415 | Myanmar | 22 |
Netherlands | 19,580 | Cuba | 396 | Tanzania | 22 |
Canada | 17,883 | Burkina Faso | 384 | Libya | 20 |
Brazil | 14,049 | Albania | 383 | Antigua and Barbuda | 19 |
Austria | 12,519 | Taiwan | 376 | Maldives | 19 |
Portugal | 12,442 | Oman | 371 | Syria | 19 |
South Korea | 10,384 | Réunion | 358 | New Caledonia | 18 |
Israel | 9,404 | Jordan | 353 | Angola | 17 |
Sweden | 7,857 | Ivory Coast | 349 | Equatorial Guinea | 16 |
Russia | 7,497 | Honduras | 312 | Namibia | 16 |
Australia | 5,988 | Malta | 293 | Fiji | 15 |
Norway | 5,903 | Ghana | 287 | Mongolia | 15 |
Ireland | 5,709 | San Marino | 279 | Dominica | 14 |
Chile | 5,116 | Niger | 278 | Laos | 14 |
Denmark | 5,071 | Mauritius | 268 | Saint Lucia | 14 |
Czech Republic | 4,944 | Palestine | 261 | Liberia | 13 |
Poland | 4,848 | Nigeria | 254 | Curaçao | 13 |
India | 5,194 | Vietnam | 251 | Coral Princess | 12 |
Romania | 4,417 | Montenegro | 239 | Grenada | 12 |
Japan | 4,168 | Senegal | 237 | Sudan | 12 |
Pakistan | 4,005 | Kyrgyzstan | 228 | MS Zaandam & Rotterdam | 11 |
Ecuador | 3,995 | Georgia | 196 | Zimbabwe | 11 |
Malaysia | 3,963 | Bolivia | 194 | Saint Kitts and Nevis | 11 |
Philippines | 3,764 | Sri Lanka | 185 | Seychelles | 11 |
Luxembourg | 2,970 | Faroe Islands | 184 | Greenland | 11 |
Peru | 2,954 | Kosovo | 184 | Suriname | 10 |
Saudi Arabia | 2,795 | DR Congo | 180 | Akrotiri and Dhekelia | 10 |
Mexico | 2,785 | USS Theodore Roosevelt | 173 | Mozambique | 10 |
Indonesia | 2,738 | Kenya | 172 | Chad | 10 |
Serbia | 2,447 | Mayotte | 171 | Eswatini | 10 |
United Arab Emirates | 2,359 | Jersey | 170 | Åland Islands | 9 |
Finland | 2,308 | Guernsey | 166 | Nepal | 9 |
Thailand | 2,258 | Venezuela | 166 | Central African Republic | 8 |
Panama | 2,249 | Bangladesh | 164 | Northern Mariana Islands | 8 |
Qatar | 2,057 | Martinique | 152 | Malawi | 8 |
Dominican Republic | 1,956 | Isle of Man | 150 | Turks and Caicos Islands | 8 |
Colombia | 1,780 | Guinea | 144 | Montserrat | 8 |
Greece | 1,755 | Guadeloupe | 139 | St. Vincent & the Grenadines | 8 |
South Africa | 1,749 | Brunei | 135 | Somalia[am] | 8 |
Argentina | 1,628 | Guam | 121 | Belize | 7 |
Iceland | 1,586 | Cambodia | 117 | Cape Verde | 7 |
Singapore | 1,481 | Paraguay | 115 | Vatican City | 7 |
Ukraine | 1,462 | Gibraltar | 113 | Botswana | 6 |
Egypt | 1,450 | Rwanda | 105 | Mauritania | 6 |
Algeria | 1,423 | Trinidad and Tobago | 105 | Nicaragua | 6 |
Croatia | 1,282 | Northern Cyprus | 91 | Saint Barthélemy | 6 |
Morocco | 1,184 | Djibouti | 90 | Sierra Leone | 6 |
Estonia | 1,149 | Madagascar | 88 | Donetsk People's Republic | 5 |
Moldova | 1,056 | Monaco | 79 | Bhutan | 5 |
Slovenia | 1,055 | El Salvador | 78 | Gambia | 4 |
Iraq | 1,031 | Guatemala | 77 | Luhansk People's Republic | 4 |
New Zealand | 969 | Liechtenstein | 77 | São Tomé and Príncipe | 4 |
Hong Kong | 936 | Aruba | 74 | Anguilla | 3 |
Hungary | 895 | French Guiana | 72 | British Virgin Islands | 3 |
Lithuania | 880 | Togo | 65 | Burundi | 3 |
Belarus | 861 | Barbados | 63 | Falkland Islands | 2 |
Armenia | 853 | Jamaica | 63 | Papua New Guinea | 2 |
Bahrain | 811 | Mali | 56 | Sint Eustatius | 2 |
Bosnia and Herzegovina | 764 | Ethiopia | 52 | Somaliland | 2 |
Kuwait | 743 | Uganda | 52 | South Sudan | 2 |
Azerbaijan | 717 | French Polynesia | 47 | Abkhazia | 1 |
Diamond Princess | 712 | Cayman Islands | 45 | Artsakh | 1 |
Cameroon | 685 | Republic of the Congo | 45 | East Timor | 1 |
Kazakhstan | 685 | Macau | 44 | Guantanamo Bay | 1 |
Tunisia | 623 | U.S. Virgin Islands | 45 | Saint Pierre and Miquelon | 1 |
North Macedonia | 599 | Sint Maarten | 40 |